Stock listing
LOBE Stock Price, News, Filings & Events — Lobe Sciences Ltd
Selected listing: LOBE · CSE · CAD · CA
This page tracks Lobe Sciences Ltd's LOBE:CSE listing on CSE in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LOBE:CSE. LOBE:CSE is the stock-level entry point for investors researching Lobe Sciences Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lobe Sciences Ltd, trading under the ticker LOBE, is a public company based in Canada with a market capitalization of approximately CAD 18.15 million. The company focuses on developing innovative solutions in the health and wellness sector. Lobe Sciences aims to leverage its expertise to address various challenges in the industry.

- Ticker
- LOBE:CSE
- Asset type
- Stock
- Market cap
- $17.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- CSE
- Currency
- CAD
Lobe Sciences Ltd LOBE:CSE stock context
This page tracks Lobe Sciences Ltd's LOBE:CSE listing on CSE in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LOBE:CSE. LOBE:CSE is the stock-level entry point for investors researching Lobe Sciences Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lobe Sciences Ltd, trading under the ticker LOBE, is a public company based in Canada with a market capitalization of approximately CAD 18.15 million. The company focuses on developing innovative solutions in the health and wellness sector. Lobe Sciences aims to leverage its expertise to address various challenges in the industry.
Latest news from Lobe Sciences Ltd
Lobe Sciences to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
September 14, 2026
Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
August 31, 2026
Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
August 28, 2026
Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
August 20, 2026
Lobe Sciences Reports Third Quarter 2026 Financial Results
August 18, 2026
Research Lobe Sciences Ltd
Lobe Sciences Ltd investor report
Review AI stock analysis and investor report context for LOBE:CSE.
Lobe Sciences Ltd company profile
View the public company page for Lobe Sciences Ltd on 6ix.
Lobe Sciences Ltd news
Read company news and market updates connected to Lobe Sciences Ltd.
Lobe Sciences Ltd investor events
Find investor webinars, events, and replay context for Lobe Sciences Ltd.
Alternate listings
LOBEF:OTC
US · USD
Alternate listing for Lobe Sciences Ltd; the primary context on this page is LOBE:CSE.
LOBE:NEO
CA · CAD
Alternate listing for Lobe Sciences Ltd; the primary context on this page is LOBE:CSE.
LOBE:FWB
DE · EUR
Alternate listing for Lobe Sciences Ltd; the primary context on this page is LOBE:CSE.